Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Clinical Pharmacokinetics|May 1, 1993
Pharmacokinetic optimisation in the treatment of Pneumocystis carinii pneumoniaH F Vöhringer, K ArastéhInternational Journal of Clinical Pharmacology, Therapy, and Toxicology|April 1, 1981
Digitalis therapy in renal failure with special regard to digitoxinH F Vöhringer, N RietbrockMedizinische Klinik (Munich, Germany : 1983)|July 15, 1993
[Comparison of the clinical effect between digoxin and a diuretic in chronic left heart failure and sinus rhythm]H F Vöhringer, K P SchürenFortschritte Der Medizin|April 14, 1977
[Pharmacokinetics of cardiac glycosides and clinical consequences]N Rietbrock, J Kuhlmann, H F VöhringerDeutsche Medizinische Wochenschrift (1946)|January 23, 1976
[Influence of antacids on plasma concentration of digoxin in man (author's transl)]H F Vöhringer, J Kuhlmann, N RietbrockFortschritte Der Medizin|October 13, 1977
[The biological availability of digitoxin]H F Vöhringer, H M Wogenstein, N RietbrockKlinische Wochenschrift|July 1, 1977
[Isomerisation and bioavailability of beta- and alpha-acetyldigoxin (author's transl)]N Rietbrock, H F Vöhringer, J Kuhlmann, et al.Medizinische Klinik (Munich, Germany : 1983)|April 1, 1990
[Pharmacologic studies with pentamidine aerosol in HIV patients]H F Vöhringer, K Arasteh, E Hardtmann, et al.Clinical Pharmacology and Therapeutics|January 1, 1981
Verapamil disposition in liver disease and intensive-care patients: kinetics, clearance, and apparent blood flow relationshipsB G Woodcock, I Rietbrock, H F Vöhringer, et al.Arzneimittel-Forschung|July 1, 1977
Influence of canrenoate-K and cardiac glycosides on their tissue distribution and eliminationJ Kuhlmann, V Kötter, H F Vöhringer, et al.Pageof 2